Exercise, Rehab Services Can Be Integrated Into Breast Cancer Care
By Lori Solomon HealthDay Reporter
MONDAY, April 28, 2025 -- Exercise and rehabilitation services for patients with breast cancer through a clinical workflow algorithm called CORE (Comprehensive Oncology Rehabilitation and Exercise) is feasible and acceptable to patients, according to a study published online April 28 in Cancer.
Lea Haverbeck Simon, Ph.D., from the Huntsman Cancer Institute at the University of Utah in Salt Lake City, and colleagues evaluated the feasibility and acceptability of the CORE clinical workflow algorithm. The analysis included 72 patients with newly diagnosed stage I to III breast cancer needing surgery as first-line treatment who were randomly assigned (2:1) to CORE or standard of care.
The researchers found that 93 percent of participants in CORE completed the triaging tool, demonstrating its feasibility. Among those triaged to a service pathway, 62 percent completed their referral. Focus groups provided primarily positive feedback.
"CORE may serve as a model workflow algorithm aimed to integrate both exercise and rehabilitation services from time of diagnosis and beyond," senior author Adriana M. Coletta, Ph.D., also from the Huntsman Cancer Institute, said in a statement. "Findings from this trial support national efforts led by the American College of Sports Medicine to integrate exercise and rehabilitation services as part of routine cancer care."
One author disclosed receiving personal/consulting fees from ImpediMed.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
Outcomes With Immune Checkpoint Inhibitors Similar for Older, Younger Patients
TUESDAY, April 29, 2025 -- Patients with cancer aged 65 years and older receiving immune checkpoint inhibitors (ICIs) derive similar clinical outcomes as younger patients...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.